The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Eplerenone
Eplerenone · EPLERENONE 50 mg/1 · Tablet, Coated · Oral · AvKARE
NDC 42291-0455-90 · 90 TABLET, COATED in 1 BOTTLE · ANDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Part D plans paid (avg)$1.08per dosage unitgross, before rebates — matched by drug name · 2024
- Federal contracts pay (FSS)$0.7690per unitAvKare, LLC · Feb 1, 2026
- List price (WAC, as filed)$113.36per packageAvKare · Feb 1, 2026
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$75.81
Reported to Texas DSHS · 2026 annual filing · AvKare
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for eplerenone (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA207842
- TE code
- AB
- Approval date
- Oct 25, 2021
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Eplerenone (Tablet, Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AvKARE | EPLERENONE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvKARE | EPLERENONE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | EPLERENONE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | EPLERENONE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | EPLERENONE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Westminster Pharmaceuticals, LLC | EPLERENONE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Westminster Pharmaceuticals, LLC | EPLERENONE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Eplerenone — NDC 42291-0455-90," retrieved September 3, 2026, https://drugdashboards.com/drug/42291045590.
Free to cite with attribution — see how the data is put together.